94 results
Page 4 of 5
8-K
EX-99.1
k3wv5gwu
22 Feb 21
Pulse Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
4:18pm
8-K
EX-99.1
qohh9
4 Feb 21
Pulse Biosciences, Inc. Announces At-The-Market Equity Offering Program
8:30am
8-K
EX-99.1
5sfaxh6c4md3ha0
3 Feb 21
Pulse Biosciences Announces FDA Clearance for the CellFX® System
4:13pm
8-K
EX-99.1
it5e0573bt gpgvxgg91
25 Jan 21
Pulse Biosciences Announces CE Mark Approval for CellFX® System
8:12am
8-K
EX-99.1
qml9i sdhlm27ntgm14
5 Jan 21
Pulse Biosciences, Inc. Announces Redemption of Warrants
9:16am
8-K
EX-99.1
u48tyah y9o
9 Nov 20
Pulse Biosciences Reports Third Quarter 2020 Financial Results
4:29pm
8-K
EX-99.1
4o93lyh0pw aa
10 Aug 20
Pulse Biosciences Reports Second Quarter 2020 Financial Results
4:27pm
8-K
EX-99.1
arqi02uca5e
6 Aug 20
Pulse Biosciences, Inc. Appoints Richard van den Broek to Board of Directors
5:00pm
8-K
EX-99.1
drxprx58
17 Jun 20
Pulse Biosciences, Inc. Announces Closing of $30 Million Rights Offering
12:00am
8-K
EX-99.1
9w4 mubf93
9 Jun 20
Pulse Biosciences, Inc. Announces Preliminary Results for Its Oversubcribed Rights Offering
12:00am
8-K
EX-99.1
qvnafz1veo3 t29
15 May 20
Pulse Biosciences, Inc. Announces Commencement of Rights Offering
12:00am
8-K
EX-99.1
67and3s 5otr8
11 May 20
Pulse Biosciences Reports First Quarter 2020 Financial Results
4:16pm
8-K
EX-99.1
7mq0i
1 May 20
Pulse Biosciences, Inc. Announces Updated Structure, Dates and Pricing Terms for Rights Offering
9:15am
8-K
EX-99.1
1640bd qp41
6 Apr 20
Pulse Biosciences files Registration Statement for Rights Offering
9:15am
8-K
EX-99.1
xj28n8au1 mbc9
16 Mar 20
Pulse Biosciences Report Fourth Quarter and Full Year 2019 Financial Results
4:32pm